Literature DB >> 26892076

Early outcomes after isolated aortic valve replacement with rapid deployment aortic valve.

Thorsten C W Wahlers1, Axel Haverich2, Michael A Borger3, Malakh Shrestha2, Alfred A Kocher4, Thomas Walther5, Matthias Roth5, Martin Misfeld3, Friedrich W Mohr3, Joerg Kempfert5, Pascal M Dohmen6, Christoph Schmitz7, Parwis Rahmanian8, Dominik Wiedemann4, Francis G Duhay9, Günther Laufer4.   

Abstract

OBJECTIVE: Minimal access aortic valve replacement is associated with favorable clinical outcomes; however, several meta-analyses have reported significantly longer crossclamp times compared with a full sternotomy. We examined the procedural and early safety outcomes after isolated rapid deployment aortic valve replacement by surgical approach in patients enrolled in the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve trial.
METHODS: The Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve trial was a prospective, multicenter, single-arm study, with successful implants in 287 patients with aortic valve stenosis who underwent rapid deployment aortic valve replacement using the EDWARDS INTUITY Valve System (Edwards Lifesciences, Irvine, Calif). Patients were evaluated perioperatively for procedural times and technical success rates; at discharge, for hospital length of stay; and, at 30 days, for early adverse events.
RESULTS: A total of 158 patients underwent isolated aortic valve replacement through a full sternotomy (n = 71), upper hemisternotomy (n = 77), or right anterior thoracotomy (n = 10). Mean age at baseline was 75.7 ± 7.2 years. Mean aortic crossclamp and cardiopulmonary bypass times (minutes) were similar for full sternotomy and upper hemisternotomy, 43.5 ± 32.5/71.6 ± 41.8 and 43.1 ± 13.1/69.6 ± 19.1, respectively, and significantly longer for right anterior thoracotomy, 88.3 ± 18.6/122.2 ± 22.1 (P < .000). Early adverse event rates were similar, and in-hospital mortality rates were low regardless of surgical approach.
CONCLUSIONS: These data suggest that isolated rapid deployment aortic valve replacement through an upper hemisternotomy can lead to shorter crossclamp times than has been reported historically in the literature. This may facilitate minimal access aortic valve replacement by eliminating the issue of prolonged crossclamp times. Further, low in-hospital mortality and new permanent pacemaker implant rates were observed regardless of surgical approach.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic valve; bioprosthesis; heart valve; hemodynamics; replacement

Mesh:

Year:  2016        PMID: 26892076     DOI: 10.1016/j.jtcvs.2015.12.058

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Need for permanent pacemaker implantation following implantation of the rapid deployment valve in combined procedures: a single centre cohort study.

Authors:  Oliver Deutsch; Isabell Deisenhofer; Katharina Koch-Buettner; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

2.  Initial Experience with Aortic Valve Replacement via a Minimally Invasive Approach: A Comparison of Stented, Stentless and Sutureless Valves.

Authors:  Johanna Konertz; Konstantin Zhigalov; Alexander Weymann; Pascal M Dohmen
Journal:  Med Sci Monit       Date:  2017-04-05

3.  Benefits of rapid deployment aortic valve replacement with a mini upper sternotomy.

Authors:  Siobhan Chien; Callum Clark; Saumya Maheshwari; Charilaos-Panagiotis Koutsogiannidis; Vipin Zamvar; Vincenzo Giordano; Kelvin Lim; Renzo Pessotto
Journal:  J Cardiothorac Surg       Date:  2020-08-26       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.